Keyphrases
COVID-19
100%
Fetus
100%
BNT162b2 Vaccine
100%
Neonatal Transfer
100%
Parturient
66%
Israel
33%
Significant Risk Factors
33%
Medical Center
33%
Titer
33%
Inoculation
33%
Pregnant Women
33%
During Pregnancy
33%
Neonate
33%
Vaccine Effectiveness
33%
Maternal Blood
33%
Substantial Evidence
33%
Second Trimester
33%
Third Trimester
33%
At Birth
33%
Transfer Ratio
33%
Unvaccinated
33%
First Dose
33%
Sufficient Evidence
33%
Humoral Response
33%
IgM Response
33%
Umbilical Cord
33%
IgG Response
33%
Fetal Blood Sampling
33%
Anti-S
33%
MRNA Vaccine
33%
Serum IgG
33%
BNT162b2
33%
Vaccination in Pregnancy
33%
Placenta Barrier
33%
Fetal Immune System
33%
IgG Titer
33%
Anti-RBD IgG
33%
Native Infection
33%
IgM Titer
33%
COVID-19 in Pregnancy
33%
COVID-19 Antibody
33%
SARS-CoV-2 Antigen
33%
Serum IgM
33%
Anti-COVID-19
33%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
COVID-19 Vaccine
100%
Messenger RNA
100%
Infection
75%
COVID-19
50%
Immunoglobulin M
50%
mRNA Vaccine
50%
Neonatal Infant
25%
Neonate
25%
Umbilical Cord
25%
Immune Response
25%
Sensitization
25%
Third Trimester Pregnancy
25%
Humoral Immunity
25%
Blood Placenta Barrier
25%
Second Trimester Pregnancy
25%
Progeny
25%
Immunology and Microbiology
COVID-19
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Immunology
100%
Immunoglobulin M
50%
Titer
50%
Progeny
25%
Immune Response
25%
Humoral Immunity
25%
Sensitization
25%
Blood Placenta Barrier
25%
Second Trimester Pregnancy
25%
Umbilical Cord
25%
Third Trimester Pregnancy
25%
Biochemistry, Genetics and Molecular Biology
SARS Coronavirus
100%
Messenger RNA
100%
Titer
50%
Immunoglobulin M
50%
Progeny
25%
Immune Response
25%
Second Trimester Pregnancy
25%
Third Trimester Pregnancy
25%
Blood Placenta Barrier
25%
Humoral Immunity
25%
Sensitization
25%